BSX
Boston Scientific Corporation
NYSE · Healthcare · Medical - Devices · US
$47.73
+1.65%Forward multiples
Based on analyst estimates
- P/E forward
- 14.39x
- P/E 2026E
- 14.30x
- P/E 2027E
- 13.81x
- P/E 2028E
- 12.54x
- P/S forward
- 3.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.24x
- PEG TTM
- 0.57x
- Price / book
- 2.77x
- Price / sales
- 3.29x
- Price / cash flow
- 15.27x
Enterprise value
- Enterprise value
- $81.5B
- EV / sales
- 3.88x
- EV / EBITDA
- 14.34x
- EV / EBIT
- 18.09x
- Market cap
- $69.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026